Teva Fights For Biaxin Marketing Rights

Law360, New York (April 19, 2007, 12:00 AM EDT) -- A protracted legal battle between Teva Pharmaceuticals USA and Abbott Laboratories took a new turn on Tuesday, with Teva filing a lawsuit seeking a declaratory judgment that its marketing of a generic version of Abbott’s extended-release antibiotic Biaxin is in line with a settlement the companies reached last August.

Teva said in court documents filed Tuesday in the U.S. District Court for the Southern District of New York that it filed the declaratory judgment action after counsel for Abbott told Teva attorneys that Abbott believes Teva’s...
To view the full article, register now.